ReviewActa pharmacologica Sinica2016

Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.

Rui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.